Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 11.43x is 27% above its 5-year average of 8.98x, near the high end of its 5-year range (-42.08x–15.37x).
1715.48% above its 12-month average of 0.63x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -42.08x.
INTEREST COVERAGE RATIO
11.43x
INTEREST COVERAGE RATIO AVG TTM
0.63x
INTEREST COVERAGE RATIO AVG 3Y
9.41x
INTEREST COVERAGE RATIO AVG 5Y
8.98x
INTEREST COVERAGE RATIO AVG 10Y
9.68x
INTEREST COVERAGE RATIO AVG 15Y
11.48x
INTEREST COVERAGE RATIO AVG 20Y
15.47x
CURRENT VS TTM AVG
+1715.48%
CURRENT VS 3Y AVG
+21.47%
CURRENT VS 5Y AVG
+27.26%
CURRENT VS 10Y AVG
+18.03%
CURRENT VS 15Y AVG
-0.40%
CURRENT VS 20Y AVG
-26.14%
SECTOR MEDIAN · HEALTHCARE
6.88x
median of 82 covered companies
CURRENT VS SECTOR MEDIAN
+66.01%
vs the sector median at left
Gilead Sciences, Inc.
Market Cap
$180.97B
Interest Coverage Ratio
11.43x
TTM Avg
0.63x
3Y Avg
9.41x
5Y Avg
8.98x
Market Cap
$178.49B
Interest Coverage Ratio
23.60x
TTM Avg
17.46x
3Y Avg
17.67x
5Y Avg
16.77x
Market Cap
$192.82B
Interest Coverage Ratio
30.34x
TTM Avg
54.30x
3Y Avg
123.94x
5Y Avg
139.58x
Market Cap
$158.76B
Interest Coverage Ratio
5.78x
TTM Avg
5.55x
3Y Avg
10.96x
5Y Avg
11.04x
Market Cap
$205.20B
Interest Coverage Ratio
3.88x
TTM Avg
3.09x
3Y Avg
3.93x
5Y Avg
4.89x
Market Cap
$140.94B
Interest Coverage Ratio
19.38x
TTM Avg
19.02x
3Y Avg
23.18x
5Y Avg
23.65x
Market Cap
$226.15B
Interest Coverage Ratio
5.71x
TTM Avg
5.17x
3Y Avg
6.77x
5Y Avg
10.10x
Market Cap
$132.25B
Interest Coverage Ratio
N/A
TTM Avg
55.58x
3Y Avg
55.58x
5Y Avg
55.58x
Market Cap
$131.70B
Interest Coverage Ratio
357.95x
TTM Avg
357.95x
3Y Avg
174.48x
5Y Avg
123.56x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. (GILD) | $180.97B | 11.43x | 0.63x | 9.41x | 8.98x |
| Abbott Laboratories (ABT)vs › | $178.49B | 23.60x | 17.46x | 17.67x | 16.77x |
| Novo Nordisk A/S (NVO)vs › | $192.82B | 30.34x | 54.30x | 123.94x | 139.58x |
| Pfizer Inc. (PFE)vs › | $158.76B | 5.78x | 5.55x | 10.96x | 11.04x |
| Amgen Inc. (AMGN)vs › | $205.20B | 3.88x | 3.09x | 3.93x | 4.89x |
| Danaher Corporation (DHR)vs › | $140.94B | 19.38x | 19.02x | 23.18x | 23.65x |
| Thermo Fisher Scientific Inc. (TMO)vs › | $226.15B | 5.71x | 5.17x | 6.77x | 10.10x |
| Intuitive Surgical, Inc. (ISRG)vs › | $132.25B | N/A | 55.58x | 55.58x | 55.58x |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $131.70B | 357.95x | 357.95x | 174.48x | 123.56x |
| Bristol-Myers Squibb Company (BMY)vs › | $131.32B | 7.26x | 6.11x | 6.76x | 6.22x |
Interest Coverage
11.4x
Debt/Equity
2.22
Current Ratio
1.27
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -42.08x |
| 2026-03-31 | 10.78x |
| 2025-12-31 | 11.72x |
| 2025-09-30 | 13.00x |
| 2025-06-30 | 9.74x |
| 2025-03-31 | 8.60x |
| 2024-12-31 | 9.85x |
| 2024-09-30 | 3.73x |
| 2024-06-30 | 11.16x |
| 2024-03-31 | -17.02x |
| 2023-12-31 | 6.40x |
| 2023-09-30 | 11.31x |
| 2023-06-30 | 7.24x |
| 2023-03-31 | 7.41x |
| 2022-12-31 | 10.03x |
| 2022-09-30 | 12.39x |
| 2022-06-30 | 8.38x |
| 2022-03-31 | 0.83x |
| 2021-12-31 | 3.95x |
| 2021-09-30 | 15.37x |
| 2021-06-30 | 8.77x |
| 2021-03-31 | 11.25x |
| 2020-12-31 | 9.93x |
| 2020-09-30 | 8.48x |
| 2020-06-30 | -12.43x |
| 2020-03-31 | 9.97x |
| 2019-12-31 | 4.50x |
| 2019-09-30 | -5.89x |
| 2019-06-30 | 9.80x |
| 2019-03-31 | 8.81x |
| 2018-12-31 | 4.45x |
| 2018-09-30 | 9.94x |
| 2018-06-30 | 8.57x |
| 2018-03-31 | 7.42x |
| 2017-12-31 | 7.71x |
| 2017-09-30 | 13.10x |
| 2017-06-30 | 15.81x |
| 2017-03-31 | 14.43x |
| 2016-12-31 | 15.26x |
| 2016-09-30 | 18.18x |
| 2016-06-30 | 19.99x |
| 2016-03-31 | 20.22x |
| 2015-12-31 | 24.44x |
| 2015-09-30 | 33.85x |
| 2015-06-30 | 40.11x |
| 2015-03-31 | 35.10x |
| 2014-12-31 | 33.22x |
| 2014-09-30 | 33.46x |
| 2014-06-30 | 43.25x |
| 2014-03-31 | 40.04x |
| 2013-12-31 | 16.36x |
| 2013-09-30 | 15.52x |
| 2013-06-30 | 14.79x |
| 2013-03-31 | 12.54x |
| 2012-12-31 | 12.89x |
| 2012-09-30 | 11.69x |
| 2012-06-30 | 11.98x |
| 2012-03-31 | 8.23x |
| 2011-12-31 | 11.57x |
| 2011-09-30 | 23.29x |
| 2011-06-30 | 22.05x |
| 2011-03-31 | 21.88x |
| 2010-12-31 | 20.42x |
| 2010-09-30 | 29.12x |
| 2010-06-30 | 55.88x |
| 2010-03-31 | 68.48x |
| 2009-12-31 | 61.62x |
| 2009-09-30 | 51.95x |
| 2009-06-30 | 41.17x |
| 2009-03-31 | 48.49x |
| 2008-06-30 | 36.86x |
| 2008-03-31 | 41.75x |